Filana Therapeutics, Inc. Deferred Revenue (Non-Current)
Filana Therapeutics, Inc. (FLNA) had Deferred Revenue (Non-Current) of $27.41 million as of 2013-09-30, per its 10-Q filed 2013-11-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2014-02-05
- 2013-09-30: Deferred Revenue, Noncurrent $27.41M.
- 2013-06-30: Deferred Revenue, Noncurrent $29.37M.
- 2013-03-31: Deferred Revenue, Noncurrent $31.33M.
- 2012-12-31: Deferred Revenue, Noncurrent $33.29M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2013-09-30 | $27.41M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $29.37M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $31.33M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $33.29M 10-K · filed 2014-02-05 |
| 2012-09-30 | $32.69M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $35.41M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $38.14M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $40.86M 10-K · filed 2013-02-08 |
| 2011-09-30 | $43.59M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $46.31M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $51.76M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |